Dr. Christy Joy Samaras, DO

Dr. Samaras practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Samaras' NPI, 1871581611, was assigned on October 6, 2005. Dr. Samaras graduated from University of New England, College of Osteo Medicine in 2000. Dr. Samaras holds Ohio license 34.009997.

Dr. Samaras' primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Samaras' primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Samaras is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Samaras to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Samaras' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samaras practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Samaras' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Samaras is licensed in Ohio.

CMS data shows 631 Medicare services from Dr. Samaras across 8 procedure codes in 2024, for 255 Medicare patients. Medicare paid $34,446 for them.

CMS counts 255 Medicare patients who saw Dr. Samaras in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samaras' median patient age at 66, with 56% women.

In 2024, Dr. Samaras wrote 1,281 Medicare Part D claims for 167 patients. 59% of them were for generic drugs. CMS names the drug for 1,056 of them, across 24 drugs with 11 or more claims each, at $6,699,463 in total drug cost. In 2023, CMS named 1,247 claims across 27 drugs.

Dr. Samaras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samaras as offering telehealth.

Dmand AI links 33 papers to Dr. Samaras, published from 2013 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis and Amyloidosis. Dr. Samaras has published most often in Br J Haematol. Dr. Samaras' most frequent co-authors are Jason N. Valent, MD, Faiz Anwer, MD and Sandra Mazzoni, DO.

CMS Open Payments shows 3 general payments to Dr. Samaras from 2 drug and device companies from 2018 to 2019. Speaker and faculty fees make up the largest share, 93% of the total. Celgene Corporation paid the most, $1,558. It also lists 1 research payment totaling $4,464 in 2017.

Dr. Samaras graduated from University of New England, College of Osteo Medicine in 2000.